Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 2Lymphoid 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Neoplasms 2Lymphoma, Non-Hodgkin 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma 1Hodgkin Disease 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 7Nivolumab 3poly ICLC 2durvalumab 2Rituximab 2Gemcitabine 2Capecitabine 2utomilumab 1tremelimumab 1tanespimycin 1mirabegron 1entinostat 1ciforadenant 1cemiplimab 1Vorinostat 1Thalidomide 1Specimen Handling 1SUB1 protein, human 1SRA737 1Ritonavir 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Injections, Subcutaneous 1Indinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Injections, Subcutaneous × Lymphoid × Clear all
NCT02376699 2023-05-01

Safety Study of SEA-CD40 in Cancer Patients

Seagen Inc.

Phase 1 Terminated
159 enrolled
DermatologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡